They found that CK5/6, CK14, and EGFR were more frequent in BRCA1 tumors compared to non-mutation BC (58% versus 7, 61% versus 12, 67% versus 21%, p < 0.0001 in each case, respectively) [42]. The gene discussed is BRCA1; the disease is breast cancer.